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Abstract
The increasing rate in antibiotic-resistant bacterial strains has become an imperative health issue. Thus, pharmaceutical
industries have focussed their efforts to find new potent, non-toxic compounds to treat bacterial infections. Antimicrobial
peptides (AMPs) are promising candidates in the fight against antibiotic-resistant pathogens due to their low toxicity, broad
range of activity and unspecific mechanism of action. In this context, bioinformatics’ strategies can inspire the design of new
peptide leads with enhanced activity. Here, we describe an artificial neural network approach, based on the AMP’s
physicochemical characteristics, that is able not only to identify active peptides but also to assess its antimicrobial potency.
The physicochemical properties considered are directly derived from the peptide sequence and comprise a complete set of
parameters that accurately describe AMPs. Most interesting, the results obtained dovetail with a model for the AMP’s
mechanism of action that takes into account new concepts such as peptide aggregation. Moreover, this classification
system displays high accuracy and is well correlated with the experimentally reported data. All together, these results
suggest that the physicochemical properties of AMPs determine its action. In addition, we conclude that sequence derived
parameters are enough to characterize antimicrobial peptides.
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Introduction
Antimicrobial peptides (AMPs) are molecules found in all
biological kingdoms responsible for the fight against microbial
infections in the first steps of the immunological response [1]. New
strategies developed by bacteria and other microorganisms to
evade classical antibiotics have urged the pharmaceutical industry
to develop new drugs in order to wipe out these resistant
microorganisms [2]. In particular, AMPs have been proposed as
promising candidates against these pathogens [3,4]. Although
AMPs show a low potency when compared with the small
bioactive drugs used at present, they offer counterweigh
advantages such as broad range of activity and low toxicity and
are less prone to give rise to resistant strains [5,6,7]. However,
AMPs may present some drawbacks such as serum instability [8],
degradation by proteases [9] and high production costs in the case
of large polypeptides.
Hence, some in silico methods have been developed to find
AMPs with potential therapeutic application. Several algorithms
take advantage of data mining and high-throughput screening
techniques and apply vector-like analysis to scan protein and
peptide sequences [10,11]. Other bioinformatics’ strategies include
supervised learning techniques, such as artificial neural networks
(ANN) or support vector machines (SVM), in order to evaluate
easily and reliably a great amount of complex data [12,13]. In fact,
most attempts have been centred in the prediction of highly active
peptides using quantitative structure-activity relationships (QSAR)
descriptors together with ANN [14,15,16], linear discriminant [17]
or principal component analysis [18]. These systems use mainly
3D-QSAR descriptors to detail the antimicrobial properties of
peptides. Recently, a QSAR-based ANN system was experimen-
tally validated using SPOT high-throughput peptide synthesis,
showing that this methodology can accomplish a reliable
prediction by means of conventional and ‘‘inductive’’ QSAR
descriptors [19]. However, the datasets used contained only
peptides with fixed length and the leads found were only populated
in few amino acids (W, R and K and, more limitedly, L, V and I).
Although AMPs are actually enriched in these residues, a wide
diversity in the amino acid content can be found in natural AMPs
[20].
Despite the inherent complexity in designing a prediction
system only by means of computational chemistry, the recent
methods mentioned above have made a remarkable advance.
Hence, the combined use of bioinformatics and experimental
screening techniques will be essential for the discovery and
refinement of new AMPs [21].
We report here an ANN based method that is able to correlate a
complete set of sequence-derived physicochemical properties with
antimicrobial activity. The most pioneering feature in this method
is the ability to translate the observed results in a model of action
for AMPs taking into account some new concepts such as peptide
aggregation. Additionally, we conclude that the amino acid
sequence provides us with sufficient information to accurately
predict antimicrobial peptides.
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Results and Discussion
Physicochemical descriptors of antimicrobial peptides
In order to characterize the physicochemical properties of
AMPs, we have selected eight parameters: isoelectric point (pI),
peptide length, a-helix, b-sheet and turn structure propensity, in
vivo and in vitro aggregation propensity and hydrophobicity. We
have first evaluated these descriptors in antimicrobial and non-
antimicrobial peptides to test its suitability to act as classifiers (See
the Methods section for a complete description on the peptide
datasets). The statistical distribution for each parameter is
illustrated in Figure 1.
It can be seen in Figure 1A that AMPs and non-AMPs have
similar average isoelectric points of 9.26 and 9.20, respectively.
However, the variances observed for both groups are significantly
different (p-value ,0.0001), being the data dispersion much
greater for non-AMPs. Thus, variance analysis suggest that a high
positive net charge is required for AMPs whereas it does not
represent a distinctive feature in non-AMPs, probably due to the
diverse functions exerted by these peptides.
Similar results are observed for peptide length (Figure 1B). Non-
AMPs tend to be larger than AMPs but no significant differences
can be found in the mean value though variances in both groups
differ significantly (p-value ,0.0001). The length parameter can
contribute to the antimicrobial mechanism of action by modulat-
ing the peptide insertion into the membrane [22]. It has also been
described to be an important parameter for the de-novo generation
of antimicrobial peptides [23].
Remarkable differences have been found in the analysis of the
structural parameters of these two groups (Figures 1C, 1D, 1E). In
this case, it can be observed that AMPs tend to be random coil in
solution, with a low tendency to present any defined structure. In
contrast, non-AMPs display a high proclivity to adopt a-helix or b-
sheet structure (Figure 2). These results are consistent with the
experimental data reported [22] where it has been described that
most AMPs have no structure in solution but acquire a defined
secondary structure upon membrane interaction.
We have also studied the aggregation propensity for both groups,
as it could be an important modulator of the peptide function.
Aggregation in solution has to be clearly distinguished from the
capacity of many antimicrobial peptides to form aggregates upon
interaction with cell membranes, a step required for the AMPs
mode of action (e.g. in the ‘‘carpet –like’’ mechanism [22]). Besides,
peptide aggregation on the bacteria surface has been observed in
some cell-agglutinating AMPs [24,25]. This agglutinating activity
could help bacteria clearance in the body at the infection focus [3].
It has been described that TANGO is a good predictor of
aggregation in solution, as it uses sequence-derived structural
parameters to forecast aggregation [26]. On the other hand,
AGGRESCAN is a good analyst of aggregation in bacteria, as it
has been developed in an E. coli system [27,28]. We have used
TANGO software to predict in vitro (or ‘‘in solution’’) aggregation,
whereas AGGRESCAN has been used to predict in vivo
aggregation. As we can see in Figures 1F and 1G, AMPs display
a low in vitro aggregation propensity when compared with non-
AMPs while the in vivo aggregation parameter is considerably
higher for AMPs. Additionally, great dispersion in the in vitro
aggregation propensity has also been observed for non-AMPs.
If TANGO and AGGRESCAN values are plotted together for
AMPs and non-AMPs we can observe an interesting pattern
(Figure 3). Whereas AMPs present high in vivo and very low in vitro
aggregation propensity, non-AMPs can be divided in two main
groups, presenting either high or low values for both descriptors.
These results suggest that AMPs may minimize its aggregation in
solution but promote aggregation in a more hydrophobic
environment (i.e. the bacteria cell membrane). On the contrary,
non-AMPs exhibit a dispersed aggregation pattern, probably
related to their diverse biological functions. Thus, the results
suggest that peptide’s aggregation behaviour could be useful for
classification purposes.
Figure 1. Statistical distribution of peptide physicochemical properties. Each panel corresponds to one parameter: (A) isoelectric point, (B)
length, (C) a-helix propensity, (D) b-sheet propensity, (E) turn propensity, (F) in vitro aggregation, (G) in vivo aggregation and (H) hydrophobicity. The
left box in each panel stands for the AMPs dataset and the right box to the non-AMPs dataset. Propensity values for in vitro aggregation and
secondary structure prediction were computed using the TANGO software [26]. In vivo aggregation propensity was computed using AGGRESCAN
software (The Na4vSS values computed represent the average aggregation propensity over the entire sequence divided by the number of residues
and multiplied by 100) [27]. The isoelectric point (pI) was computed using the Expasy reference values and the peptide hydrophobic mean character
using the GRAVY scale.
doi:10.1371/journal.pone.0016968.g001
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Finally, the hydrophobicity analysis (Figure 1H) shows that both
the means and the variances differ significantly between AMPs
and non-AMPs (p-value ,0.0001). AMPs need to insert, partially
or totally, into the membrane hydrophobic core in order to
destabilize the bilayer and/or promote the cell depolarization
[29]. Thus, a higher mean hydrophobicity value is expected for
AMPs.
Prediction of antimicrobial peptides by physicochemical
properties
Using the physicochemical properties described above, an ANN
system has been constructed in order to classify peptides in two
groups: AMPs and non-AMPs. We have used the CAMP peptide
database [17] to build the positive dataset and the Uniprot
database to construct the negative dataset as described in the
Methods section. After subtracting peptides containing non-
standard amino acids the two datasets together contained 2148
peptides, 1157 AMPs and 991 non-AMPs. The ANN system (see
the Methods section for further details) was evaluated using a
training dataset containing 1074 peptides. The validation and
testing datasets were populated each one with 537 peptides.
The receiver-operating curves (ROC) obtained (Figure 4) show
that the method is able to correctly classify peptides in the two
groups considered. The overall accuracy of the method was 90%,
as shown in the corresponding confusion plot (Supporting
Information, Figure S1) and is similar in both the validation and
testing datasets, meaning that there was no over fitting. The use of
50 hidden neurons was optimum for the system designed. Less
than 20 neurons consistently reduced the overall accuracy (,85%)
and more than 50 nodes did not improve the result but might
promote over convergence and a loss of model generality.
QSAR-based ANN methods described [19], using a set of 44
descriptors, obtained accuracy values near 80%. Our system can
achieve a similar or even better accuracy using only 8 parameters.
In any case, the comparison of accuracy values between the two
methodologies has to be taken with caution, as different databases
have been used. As the QSAR-based methods use two and three-
Figure 2. Structure propensity plots, showing a-helix, b-sheet and turn propensity for non-AMPs (top) and AMPs (bottom). The
propensity values were calculated using the TANGO software [26] and were rescaled from 1 to 10 to help visual inspection.
doi:10.1371/journal.pone.0016968.g002
Figure 3. In vivo and in vitro aggregation propensity plot for AMPs (red triangles) and non-AMPs (green squares). In vitro aggregation
propensity was computed using the TANGO software [26]. In vivo aggregation propensity was computed using AGGRESCAN software (The Na4vSS
values computed represent the average aggregation propensity over the entire sequence divided by the number of residues andmultiplied by 100) [27].
doi:10.1371/journal.pone.0016968.g003
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dimensional structure estimations and similar descriptors for pI
and hydrophobicity, we conclude that peptide aggregation could
be of crucial importance in our classification system. Moreover, we
have observed that structure and aggregation parameters have the
most impact when deleted in the ANN analysis (data not shown).
A support vector machine (SVM) approach has also been tested
in order to classify antimicrobial and non-antimicrobial peptides.
In this case, we have only obtained a 75% correct classification
using a 5-degree polynomial kernel (Supporting Information,
Figure S2). Thus, in our system, a SVM approach has been found
to be less accurate than the ANN approach. It is possible that the
high amount of data and the reduced space dimensionality could
favour ANNs over SVMs.
Prediction of antimicrobial peptide potency by
physicochemical properties
To go a step further in this study we have tested our model
for antimicrobial activity prediction using two independent
and non-redundant data sets. We have used the data published
by Cherkasov et al. [16] where the antimicrobial activity of
different CAMEL variants was experimentally determined.
The dataset employed is homogeneous, as all peptides were
assayed in the same conditions and thus is of great value to test
the parameters used in this study. From the 101 peptides
described, we have used an ANN to compute the antimicrobial
activity. The results obtained (Figure 5) show that our descriptors
are closely correlated with antimicrobial activity (r2 = 0.72,
q2 = 0.65).
We have also inspected the database (named RANDOM
database) described recently by Fjell et al. [19] that contents a set
of 189 peptides randomly synthesized and experimentally tested,
again in uniform conditions. The results confirm (Figure 6), once
more, a good correlation between our model and the experimental
data (r2 = 0.85, q2 = 0.72).
The successful results obtained both for peptide classification
and antimicrobial activity prediction may suggest that our set of
Figure 4. ROC curves for the training, validation, testing and global datasets showing the overall performance of the method
described.
doi:10.1371/journal.pone.0016968.g004
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parameters is complete and can appropriately describe the
antimicrobial mechanism of action of peptides.
Model design for the antimicrobial peptides mechanism
As pointed before, a major interest of the present method lies in
the ability to connect these physicochemical parameters with a
global overview on the peptide mechanism of action (Figure 7). It
is widely known that most of AMPs act mainly at the membrane
level, destabilizing the bilayer structure by creating pores (toroidal
or barrel-stave pores) or modifying its permeability by a
mechanism known as ‘‘carpet –like’’ [22]. Both models promote
the membrane depolarization and eventually the bacteria cell
death.
The first step is the membrane binding, driven by the
electrostatic interactions between the positive peptide charges
and the negative charges located in the phospholipid polar heads
[22]. It is known that, in certain conditions, some antimicrobial
peptides can form aggregates in solution before they can interact
with membranes [30,31]. Most of these aggregates have been
described to be inactive because they lack the ability to effectively
insert totally or partially in the bilayer and thus are unable to
promote the cell depolarization [32,33]. For example, the
aggregation of temporins prior to membrane interaction can
avoid its activity [34,35].
The following steps in the antimicrobial mechanism involve
membrane destabilization and diverge depending on the particular
action exerted by AMPs [22]. In a ‘‘carpet-like’’ mechanism, as
observed in dermaseptin S and cecropin [36], formation of
transmembrane structures is not necessary, but aggregation on the
membrane surface and partial insertion is critical in order to
Figure 5. Regression model for the training, validation, testing and global datasets used in the antimicrobial activity prediction for
the CAMEL peptide database. See the Methods section for a complete description of the methodology used.
doi:10.1371/journal.pone.0016968.g005
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promote destabilization and even bilayer micellization, as depicted
in Figure 7. On the contrary, formation of toroidal pores, as
observed for melittin [37], or barrel-stave pores, as observed for
alamethicin [38], require a deep insertion in the membrane and a
more ordered distribution of peptides across the bilayer.
In summary, the results presented here suggest that AMPs can
be distinguished from non-AMPs by their physicochemical
properties. We have also shown that peptide aggregation
propensity must be included in the antimicrobial mechanism of
action of peptides in order to correctly describe (and predict) its
antimicrobial capacity. In addition, we have demonstrated that
our method is able to correlate sequence-derived physicochemical
peptide properties with the antimicrobial activity and thus is a
fairly good approach to a general model able to describe and
predict antimicrobial activity.
Methods
Database selection
The CAMP database [17] was used to construct the positive
data set, containing 1157 peptides, where 95% of the peptides
ranged from 10 to 50 residues. The Uniprot database was used to
build the negative data set selecting peptides ranging between 10
and 50 amino acids length and filtered by Uniref50 in order to
avoid over representative sequence similarities. None of the 991
selected peptides were reported as antimicrobial and/or toxic.
The data described by Cherkasov et al. [16] on antimicrobial
CAMEL peptides (named CAMEL database) was used to assess
the antimicrobial activity prediction. This database is composed of
101 peptides with experimentally tested antimicrobial potency.
The data described by Fjell et al. [19] (named RANDOM
Figure 6. Regression model for the training, validation, testing and global datasets used in the antimicrobial activity prediction for
the RANDOM peptide database. See the Methods section for a complete description of the methodology used.
doi:10.1371/journal.pone.0016968.g006
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database) on different antimicrobial peptides was also indepen-
dently used to test the method. This database is composed of 189
peptides after discarding inactive peptides.
Parameter computation
In vitro aggregation and secondary structure prediction were accom-
plished by using the TANGO software [26]. Tango calculates the
partition function of the conformational phase space assuming that
every segment on the protein populates one state: random coil, b-turn,
a-helix, a-helix aggregation and b-sheet aggregation. Therefore,
TANGO software can predict aggregation in solution, taking into ac-
count only structural parameters determined by the peptide sequence.
In vivo aggregation was computed using AGGRESCAN, an
algorithm based on an amino acid aggregation-propensity scale
derived from in vivo experiments and on the assumption that short
and specific sequence stretches modulate protein aggregation. The
algorithm can actually predict the aggregation propensity of
peptides in the presence of cell material [27].
The isoelectric point (pI) was computed using the Expasy
reference values and the peptide hydrophobic mean character
using the GRAVY scale (http://expasy.org).
To study the differences in these parameters between AMPs and
non-AMPs a two-tailed unpaired t-test analysis with a confidence
interval of 95% has been used. All the parameters computed are
considered to be independent as a correlation lower than 0.9 is
observed between them in all the databases described above.
Neural network implementation
Artificial neural networks (ANN) were computed using the
Matlab software (Natick, MA). To predict antimicrobial peptides,
a two-layer feed-forward network with sigmoid hidden and
output neurons has been used. The network was trained with
scaled conjugate gradient backpropagation. Hidden layer was
populated with 50 neurons using 1074 peptides in the training
database and 537 peptides on validation and testing databases.
Both, matrix confusion plots and receiver-operative characteristic
(ROC) curves were plotted for training, validation and testing
databases.
To predict the antimicrobial potency of CAMEL and
RANDOM antimicrobial peptides, a two-layer feed-forward
network with sigmoidal hidden neurons and linear output neurons
was used. The network was trained with Levenberg-Marquardt
backpropagation algorithm. Regression plots were computed for
training, validation and testing databases. The results obtained
were cross-validated using the leave-20%-out methodology (q2
values).
Support vector machine implementation
Support vector machine (SVM) models were computed using
Gist SVM (http://svm.sdsc.edu). A training database of 1611
peptides and a testing database, containing 537 peptides, have
been used. As the model contains variables with a heterogeneous
scale, the data was adjusted to give a 0 mean value and 1 variance
value in order to enhance performance. A two norm soft margin
has been used and different polynomial kernels were tested in
order to increase accuracy.
Supporting Information
Figure S1 Confusion plot for the training, validation, testing and
global datasets showing the positive and negative true and false rates
Figure 7. Representation of the model of action for AMPs. The figure depicts the main steps in the interaction and permeabilization of the
bacterial membrane by AMPs. An arrow indicates each step. The peptide associated physicochemical parameters and the related prediction system
used is also detailed. Although charge and hydrophobicity are also involved in peptide aggregation, only Tango and Aggrescan were included to this
purpose as specific prediction systems.
doi:10.1371/journal.pone.0016968.g007
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for the method described. A legend is displayed on the top in order
to help visual inspection. Abbreviations include: TP (true positives),
FP (false positives), FN (false negatives), TN (true negatives), PPV
(positive predicting value), NPV (negative predicting value), TPR
(true positive rate or sensitivity), TNR (true negative rate or
specificity) and ACC (accuracy).
(TIF)
Figure S2 Accuracy plot as a function of the Support Vector
Machine kernel. A training database of 1611 peptides and a testing
database, containing 537 peptides, have been used. A two norm
soft margin was used in order to increase accuracy.
(TIF)
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